Thomas C. Reynolds is Chief Medical Officer at SEATTLE GENETICS INC /WA (SGEN). They have made 8 open-market trades across 2 companies since 2008, most recently 2019-12-19.
CIK 0001393945
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $16K since 2019, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MEIP | BUY | 2019-12-19 | 2019-12-20 | $1.60 | $16K | +21.1% | +27.4% | -49.9% |
| SGEN | SELL · 10b5-1 | 2013-01-25 | 2013-01-29 | $30.09 | $219K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL · 10b5-1 | 2013-01-15 | 2013-01-17 | $28.00 | $3.5M | -17.1% | -4.5% | -4.5% |
| SGEN | SELL | 2012-12-06 | 2012-12-10 | $25.77 | $1.7M | -17.1% | -4.5% | -4.5% |
| SGEN | SELL | 2012-12-04 | 2012-12-06 | $25.59 | $1.0M | -17.1% | -4.5% | -4.5% |
| SGEN | SELL | 2012-11-29 | 2012-12-03 | $25.42 | $1.0M | -17.1% | -4.5% | -4.5% |
| SGEN | SELL | 2012-11-21 | 2012-11-26 | $25.34 | $760K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL | 2012-11-19 | 2012-11-20 | $24.95 | $499K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL · 10b5-1 | 2012-09-06 | 2012-09-10 | $29.75 | $1.4M | -17.1% | -4.5% | -4.5% |
| SGEN | SELL · 10b5-1 | 2012-05-15 | 2012-05-17 | $19.75 | $19K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL · 10b5-1 | 2012-04-25 | 2012-04-26 | $19.75 | $790K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL · 10b5-1 | 2012-03-22 | 2012-03-23 | $19.78 | $791K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL · 10b5-1 | 2012-03-16 | 2012-03-20 | $19.75 | $790K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL · 10b5-1 | 2012-01-27 | 2012-01-30 | $19.75 | $790K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL · 10b5-1 | 2011-08-01 | 2011-08-03 | $17.37 | $27K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL · 10b5-1 | 2011-05-18 | 2011-05-20 | $18.71 | $249K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL · 10b5-1 | 2011-05-13 | 2011-05-13 | $17.80 | $89K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL · 10b5-1 | 2011-04-29 | 2011-05-03 | $16.95 | $89K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL · 10b5-1 | 2010-10-11 | 2010-10-12 | $16.95 | $424K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL · 10b5-1 | 2010-09-27 | 2010-09-29 | $14.95 | $374K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL · 10b5-1 | 2010-05-03 | 2010-05-05 | $12.95 | $324K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL | 2009-07-30 | 2009-07-31 | $12.47 | $312K | -17.1% | -4.5% | -4.5% |
| SGEN | SELL | 2008-09-22 | 2008-09-24 | $12.52 | $154K | -17.1% | -4.5% | -4.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.